mani
strain
mous
hepat
viru
mhv
infect
laboratori
mice
effect
vaccin
yet
develop
altern
approach
control
mhv
diseas
use
host
cell
receptortarget
ligand
address
potenti
use
approach
monoclon
antibodi
direct
host
cell
receptor
coronaviru
administ
infant
mice
challeng
oronas
intracerebr
infant
mous
median
lethal
dose
antibodi
treatment
viruschalleng
mice
result
lower
proport
mice
target
organ
markedli
reduc
viral
titer
organ
compar
mocktreat
infect
mice
antibodytr
infect
mice
surviv
day
viral
challeng
wherea
mocktreat
infect
mice
surviv
beyond
day
viral
inocul
result
support
receptortarget
approach
intervent
coronaviru
diseas
receptortarget
approach
appear
like
te
effect
viral
diseas
viru
enter
bodi
first
replic
epitheli
cell
respiratori
intestin
tract
may
access
treatment
receptorblock
substanc
excel
model
analysi
receptortarget
approach
prevent
viral
diseas
murin
coronaviru
mous
hepat
viru
mhv
mhv
preval
viru
infect
laboratori
mous
coloni
worldwid
mani
mhv
strain
tropism
either
respiratori
intestin
mucos
surfac
identifi
receptor
strain
mhv
identifi
glycoprotein
virusoverlay
protein
blot
assay
vopba
reveal
glycoprotein
express
intestin
brush
border
membran
hepatocyt
membran
mhvsuscept
balbc
mice
mani
strain
mous
hepat
viru
mhv
infect
laboratori
mice
effect
vaccin
yet
develop
altern
approach
control
mhv
diseas
use
host
cell
receptortarget
ligand
address
potenti
use
approach
monoclon
antibodi
direct
host
cell
receptor
coronaviru
administ
infant
mice
challeng
oronas
intracerebr
infant
mous
median
lethal
dose
antibodi
treatment
viruschalleng
mice
result
lower
proport
mice
target
organ
markedli
reduc
viral
titer
organ
compar
mocktreat
infect
mice
antibodytr
infect
mice
surviv
day
viral
challeng
wherea
mocktreat
infect
mice
surviv
beyond
day
viral
inocul
result
support
receptortarget
approach
intervent
coronaviru
diseas
viral
receptor
play
import
role
determin
speci
specif
tissu
tropism
pathogenesi
anim
viral
infect
vivo
receptor
virus
mani
differ
group
recent
identifi
lead
effort
inhibit
viral
infect
vitro
vivo
block
virusreceptor
interact
receptortarget
approach
appear
like
te
effect
viral
diseas
viru
enter
bodi
first
replic
epitheli
cell
respiratori
intestin
tract
may
access
treatment
receptorblock
substanc
excel
model
analysi
receptortarget
approach
prevent
viral
diseas
murin
coronaviru
mous
hepat
viru
mhv
mhv
preval
viru
infect
laboratori
mous
coloni
worldwid
mani
mhv
strain
tropism
either
respiratori
intestin
mucos
surfac
identifi
receptor
strain
mhv
identifi
glycoprotein
virusoverlay
protein
blot
assay
vopba
reveal
glycoprotein
express
intestin
brush
border
membran
hepatocyt
membran
mhvsuscept
balbc
mice
compar
membran
prepar
genet
resist
sjl
mice
bind
studi
suggest
genet
base
suscept
may
determin
least
part
express
virusbind
moieti
plasma
membran
normal
target
tissu
mhv
panel
antibodi
mab
reactiv
put
receptor
develop
one
design
prevent
bind
murin
fibroblast
block
infect
mous
cell
line
four
prototyp
mhv
strain
unpublish
data
crossneutr
specif
inhibit
mhv
infect
support
fact
titer
vesicular
stomat
indiana
serotyp
sendai
theiler
mous
encephalomyel
virus
ident
mocktreat
mhvsuscept
nctc
cell
data
shown
evid
mhv
receptorspecif
antibodi
deriv
fact
affinitypurifi
protein
elut
prepar
sdspage
specif
bound
vopba
thu
sought
determin
whether
modul
cours
infect
natur
host
expos
presum
natur
rout
viru
wasorigin
obtain
alcc
rockvil
md
use
form
infect
lysat
mice
pregnant
balbcj
balbcbyj
mice
obtain
jackson
laboratori
bar
harbor
pool
result
two
stock
balbc
mice
shown
sinc
differ
iii
pathogenesi
ofmhv
infect
note
unpublish
data
infant
cr
orl
sencar
randombr
mice
anim
genet
product
branch
nation
cancer
institut
bethesda
md
use
quantif
infecti
viru
balbc
tissu
mabccl
mab
direct
receptor
mhv
develop
describ
briefli
spleen
cell
receptorneg
sjl
mice
immun
intestin
brush
border
membran
mhvsuscept
balbc
mice
fuse
myeloma
cell
mab
specif
mhv
receptor
select
reactiv
elisa
receptor
elut
prepar
sdspageofbalbc
brush
border
membran
reactiv
immunoblot
balbc
sjl
brush
border
membran
pretreat
mous
cell
line
mab
block
infect
suggest
glycoprotein
receptor
cell
antireceptor
mabccl
highest
titer
block
infect
line
mous
fibroblast
protect
result
block
virion
bind
cell
membran
unpublish
data
mab
bound
specif
apic
brush
border
membran
frozen
section
balbc
mous
small
intestin
membran
sjl
mous
intestin
select
determin
whether
infect
diseas
caus
suscept
mice
could
prevent
vivo
antireceptor
antibodi
experiment
design
assess
vivo
protect
infant
balbc
mice
treat
three
time
daili
antireceptor
mabcci
ng
proteinmouseday
jli
oronas
jli
intraperiton
treatment
begin
day
life
control
mice
similarli
treat
pb
mab
isotyp
mabcci
direct
irrelev
antigen
mous
iggl
antidengu
viru
mab
control
mice
challeng
oronas
infant
mous
intracerebr
ic
ldso
jli
salin
day
age
thrice
daili
oronas
treatment
surviv
mice
antibodi
buffer
continu
day
challeng
randomli
select
mice
kill
ga
necropsi
day
viral
inocul
viru
homogen
nose
brain
liver
collect
infect
mice
day
viral
infect
quantifi
viru
per
gram
tissu
sensit
ldsoassay
base
ic
inocul
infant
sencar
mice
tissu
section
collect
bufferor
mabccitr
infect
mice
day
viral
inocul
infect
mice
day
inocul
examin
microscop
buffertr
infect
mice
live
beyond
day
viral
exposur
statisticalanalysi
differ
proport
analyz
x
differ
viral
titer
treatment
group
analyz
student
unpair
test
exposur
suscept
mice
mhv
strain
primari
tropism
respiratori
tract
result
neural
transport
viru
brain
bloodborn
dissemin
viscer
organ
therefor
nose
brain
liver
chosen
indic
effect
mabccl
treatment
infect
proport
mice
viru
could
recov
lower
mice
case
tabl
statist
signific
differ
brain
liver
day
viral
inocul
although
nasal
tissu
pbsand
mab
infect
mice
contain
viru
day
inocul
viral
titer
looofoldlow
nose
mice
figur
viral
titer
day
also
lower
brain
liver
infect
mice
treat
statist
signific
differ
brain
titer
day
rel
high
viral
titer
shown
liver
mabccl
treatment
group
day
repres
singl
mous
viru
could
recov
mean
viral
titer
liver
mice
day
viral
exposur
lower
mean
titer
liver
buffertr
mice
howev
statist
signific
primarili
due
small
number
surviv
buffertr
infect
mice
mabccl
alon
caus
sign
diseas
uninfect
infant
mice
treat
describ
week
result
small
number
mice
treat
anti
dengu
viru
mab
essenti
ident
shown
pbstreat
infect
mice
buffertr
infect
mice
schedul
necropsi
die
averag
day
death
add
wherea
infect
mice
schedul
necropsi
die
add
howev
two
infect
mice
surviv
necropsi
day
viral
inocul
buffertr
infect
mice
surviv
beyond
day
viral
challeng
buffertr
infect
mice
necrot
rhiniti
day
viral
exposur
mice
also
sever
hepat
evid
grossli
microscop
wherea
liver
infect
mice
histolog
normal
day
inocul
lesion
note
infect
mice
consist
necrosi
anterior
nose
day
viral
inocul
nasal
lesion
enceph
day
viral
challeng
earlier
studi
show
mhv
given
intranas
gain
access
brain
neuron
pathway
wherea
transport
organ
via
viremia
report
experi
show
mabccl
treatment
reduc
primari
replic
nose
delay
prevent
viral
spread
replic
secondari
target
organ
brain
liver
absenc
nasal
lesion
among
mice
day
later
appear
day
suggest
mhv
replic
nose
delay
treatment
pathogenesi
infect
parent
compar
viru
nasal
homogen
infect
mous
collect
studi
oronas
exposur
infant
mice
inocula
induc
fatal
diseas
qualit
similar
lesion
spectrum
organ
data
shown
find
suggest
viru
recov
organ
mabccltreat
mice
repres
select
variant
popul
studi
requir
determin
complet
protect
viral
infect
afford
challeng
lower
dose
viru
administr
concentr
antireceptor
antibodi
frequent
administr
ofth
antibodi
howev
rel
small
amount
antireceptor
antibodi
yield
protect
effect
overwhelm
inoculum
administ
natur
rout
mani
strain
mhv
infect
one
strain
afford
protect
challeng
heterolog
strain
likelihood
develop
effect
vaccin
preval
murin
viru
therefor
remot
mabccl
block
activ
gener
sens
protect
cultur
cell
infect
varieti
mhv
strain
vitro
unpublish
data
current
vivo
experi
suggest
treatment
antireceptor
antibodi
receptortarget
drug
could
protect
least
limit
number
valuabl
laboratori
mice
risk
mhv
epizoot
studi
demonstr
signific
protect
viral
infect
vivo
antibodi
direct
host
cell
receptor
possibl
complic
approach
normal
cellular
function
receptor
mhv
unknown
block
receptor
antibodi
could
interfer
function
howev
experi
promis
advers
effect
treatment
mabcci
observ
vitro
unpublish
data
vivo
possibl
virusbind
domain
mhv
receptor
glycoprotein
differ
domain
host
cell
function
evid
hypothesi
stem
observ
homolog
protein
antigen
relat
balbc
mhv
receptor
sjl
intestin
hepatocyt
membran
howev
sjl
protein
fail
bind
mabccl
numer
coronavirus
identifi
host
speciesspecif
human
coronavirus
like
mous
ubiquit
identif
host
cell
receptor
agent
signific
impact
human
health
human
coronavirus
commonli
caus
respiratori
infect
account
cold
remain
cold
predominantli
caus
rhinovirus
vaccin
rhinovirus
prove
practic
serotyp
genu
howev
drug
target
receptor
rhinovirus
might
prove
use
sinc
two
receptor
serotyp
nose
drop
contain
antibodi
receptor
major
group
rhinovirus
reduc
overal
infect
ill
rate
among
challeng
human
volunt
reduc
viral
titer
delay
viral
shed
solubl
intracellular
adhes
moleculei
recent
shown
inhibit
bind
rhinoviru
cultur
cell
protect
cytopath
effect
induc
picornavirus
use
major
group
rhinoviru
receptor
studi
suggest
receptortarget
approach
prevent
coronaviru
infect
worthi
studi
ifth
receptor
human
coronavirus
homolog
glycoprotein
receptor
murin
coronaviru
oronas
treatment
receptortarget
ligand
might
also
use
approach
prevent
human
coronaviru
infect
